Liyan Xue

3.3k total citations
137 papers, 1.9k citations indexed

About

Liyan Xue is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Liyan Xue has authored 137 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Pulmonary and Respiratory Medicine, 70 papers in Surgery and 45 papers in Oncology. Recurrent topics in Liyan Xue's work include Esophageal Cancer Research and Treatment (50 papers), Gastric Cancer Management and Outcomes (48 papers) and Esophageal and GI Pathology (20 papers). Liyan Xue is often cited by papers focused on Esophageal Cancer Research and Treatment (50 papers), Gastric Cancer Management and Outcomes (48 papers) and Esophageal and GI Pathology (20 papers). Liyan Xue collaborates with scholars based in China, United States and Netherlands. Liyan Xue's co-authors include Ning Lü, Yongmei Song, Qimin Zhan, Sanford M. Dawsey, Zitong Zhao, Yantao Tian, Fuhai Ma, Shun He, Bingzhi Wang and Jacques Bergman and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Liyan Xue

128 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liyan Xue China 26 807 734 642 515 322 137 1.9k
Maria O’Donovan United Kingdom 26 918 1.1× 1.4k 1.9× 533 0.8× 509 1.0× 265 0.8× 58 2.1k
Toshio Kuwai Japan 28 813 1.0× 826 1.1× 717 1.1× 1.1k 2.2× 474 1.5× 117 2.2k
Paola Parente Italy 23 403 0.5× 686 0.9× 268 0.4× 524 1.0× 233 0.7× 130 1.6k
Weixun Zhou China 20 447 0.6× 359 0.5× 571 0.9× 596 1.2× 337 1.0× 143 1.8k
Toru Nakamura Japan 23 722 0.9× 993 1.4× 405 0.6× 1.1k 2.2× 255 0.8× 138 2.0k
Minako Hirahashi Japan 24 654 0.8× 688 0.9× 290 0.5× 533 1.0× 141 0.4× 81 1.5k
Tingguo Zhang China 26 361 0.4× 404 0.6× 626 1.0× 451 0.9× 276 0.9× 67 1.5k
Zhi Zhu China 23 489 0.6× 340 0.5× 634 1.0× 479 0.9× 304 0.9× 88 1.5k
Simona Gurzu Romania 21 336 0.4× 420 0.6× 487 0.8× 671 1.3× 316 1.0× 165 1.6k
Kazuo Koyanagi Japan 22 640 0.8× 697 0.9× 529 0.8× 796 1.5× 350 1.1× 116 1.8k

Countries citing papers authored by Liyan Xue

Since Specialization
Citations

This map shows the geographic impact of Liyan Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyan Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyan Xue more than expected).

Fields of papers citing papers by Liyan Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liyan Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyan Xue. The network helps show where Liyan Xue may publish in the future.

Co-authorship network of co-authors of Liyan Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Liyan Xue. A scholar is included among the top collaborators of Liyan Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liyan Xue. Liyan Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yafan, Liyan Xue, Xiankai Chen, et al.. (2025). Lymph Node Metastasis for pN+ Superficial Esophageal Squamous Cell Carcinoma. Thoracic Cancer. 16(1). e15504–e15504. 1 indexed citations
2.
3.
Cheng, Xian, et al.. (2025). Genomic Instability is Widespread in Esophageal Squamous Dysplasia and Increases During the Progression to Cancer. Frontiers in Bioscience-Landmark. 30(10). 41107–41107.
4.
Kang, Xiaozheng, Liyan Xue, Xiaotian Zhao, et al.. (2024). Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 Trial. Clinical Cancer Research. 30(22). 5061–5072. 4 indexed citations
5.
Yang, Zhenlin, He Tian, Bozhao Li, et al.. (2024). Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma. Nature Communications. 15(1). 9097–9097. 25 indexed citations
6.
7.
Fan, Tao, Shan Muhammad, Xiao Chu, et al.. (2023). H3K4me3-related lncRNAs signature and comprehensive analysis of H3K4me3 regulating tumor immunity in lung adenocarcinoma. Respiratory Research. 24(1). 122–122. 4 indexed citations
8.
9.
Li, Zhuo, et al.. (2023). Tumor budding and tumor‐infiltrating lymphocytes can predict prognosis in pT1b esophageal squamous cell carcinoma. Thoracic Cancer. 14(25). 2608–2617. 8 indexed citations
10.
Wang, Zhen, Xiankai Chen, Yong Li, et al.. (2022). Phase Ib trial of camrelizumab combined with chemotherapy and apatinib for neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma. SHILAP Revista de lepidopterología. 2(2). 98–105. 8 indexed citations
11.
Yang, Zhaoyang, Hua Lin, Zhen Wang, et al.. (2022). The prognostic significance of the circumferential resection margin in esophageal squamous cell carcinoma patients without neoadjuvant treatment. BMC Cancer. 22(1). 1180–1180. 2 indexed citations
12.
Zhang, Zhihui, Yuejun Luo, Chaoqi Zhang, et al.. (2021). An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer. Cancer Cell International. 21(1). 6 indexed citations
13.
Fan, Tao, Yu Liu, Liyu Wang, et al.. (2021). Comprehensive analysis of a chemokine- and chemokine receptor family-based signature for patients with lung adenocarcinoma. Cancer Immunology Immunotherapy. 70(12). 3651–3667. 15 indexed citations
14.
Wang, Xiaohui, Zheng Li, Hao Zhao, et al.. (2020). Construction and Analysis of the Tumor-Specific mRNA–miRNA–lncRNA Network in Gastric Cancer. Frontiers in Pharmacology. 11. 1112–1112. 35 indexed citations
15.
Wu, Qingnan, Weimin Zhang, Liyan Xue, et al.. (2019). APC/C-CDH1–Regulated IDH3β Coordinates with the Cell Cycle to Promote Cell Proliferation. Cancer Research. 79(13). 3281–3293. 18 indexed citations
16.
Li, Jie, Benyan Wu, Tao Wu, et al.. (2019). Expression of GCRG213p, LINE-1 endonuclease variant, significantly different in gastric complete and incomplete intestinal metaplasia. Diagnostic Pathology. 14(1). 61–61. 1 indexed citations
17.
Munster, Sanne N. van, Liyan Xue, Shun He, et al.. (2019). Prospective study of endoscopic focal cryoballoon ablation for esophageal squamous cell neoplasia in China. Gastrointestinal Endoscopy. 90(2). 204–212. 7 indexed citations
18.
Yuan, Hongyu, et al.. (2018). ISG15 promotes esophageal squamous cell carcinoma tumorigenesis via c-MET/Fyn/β-catenin signaling pathway. Experimental Cell Research. 367(1). 47–55. 31 indexed citations
19.
Lu, Jun, Ning Lü, Liyan Xue, et al.. (2011). [Primary superficial small cell neuroendocrine carcinoma of esophagus: clinicopathologic and immunohistochemical analysis of 15 cases].. PubMed. 40(11). 736–40. 1 indexed citations
20.
Shao, Shujuan, Rong Liu, Yang Wang, et al.. (2010). Centrosomal Nlp is an oncogenic protein that is gene-amplified in human tumors and causes spontaneous tumorigenesis in transgenic mice. Journal of Clinical Investigation. 120(2). 498–507. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria O’Donovan Breakdown of academic impact, for papers by Toshio Kuwai Breakdown of academic impact, for papers by Paola Parente Breakdown of academic impact, for papers by Weixun Zhou Breakdown of academic impact, for papers by Toru Nakamura Breakdown of academic impact, for papers by Minako Hirahashi Breakdown of academic impact, for papers by Tingguo Zhang Breakdown of academic impact, for papers by Zhi Zhu Breakdown of academic impact, for papers by Simona Gurzu Breakdown of academic impact, for papers by Kazuo Koyanagi
Rankless by CCL
2026